Accretion Pharmaceuticals Limited (NSE:ACCPL)

Accretion Pharmaceuticals Statistics

Total Valuation

NSE:ACCPL has a market cap or net worth of INR 1.31 billion. The enterprise value is 1.39 billion.

Market Cap	1.31B
Enterprise Value	1.39B

Important Dates

The last earnings date was Friday, May 8, 2026.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

NSE:ACCPL has 11.12 million shares outstanding. The number of shares has increased by 33.57% in one year.

Current Share Class	11.12M
Shares Outstanding	11.12M
Shares Change (YoY)	+33.57%
Shares Change (QoQ)	+31.33%
Owned by Insiders (%)	73.50%
Owned by Institutions (%)	n/a
Float	2.95M

Valuation Ratios

The trailing PE ratio is 13.01.

PE Ratio	13.01
Forward PE	n/a
PS Ratio	1.45
PB Ratio	2.39
P/TBV Ratio	2.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.17, with an EV/FCF ratio of -6.00.

EV / Earnings	14.36
EV / Sales	1.55
EV / EBITDA	9.17
EV / EBIT	9.97
EV / FCF	-6.00

Financial Position

The company has a current ratio of 2.91, with a Debt / Equity ratio of 0.23.

Current Ratio	2.91
Quick Ratio	1.27
Debt / Equity	0.23
Debt / EBITDA	0.81
Debt / FCF	-0.53
Interest Coverage	16.43

Financial Efficiency

Return on equity (ROE) is 27.62% and return on invested capital (ROIC) is 16.34%.

Return on Equity (ROE)	27.62%
Return on Assets (ROA)	14.94%
Return on Invested Capital (ROIC)	16.34%
Return on Capital Employed (ROCE)	24.95%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	7.19M
Profits Per Employee	773,400
Employee Count	125
Asset Turnover	1.54
Inventory Turnover	2.66

Taxes

In the past 12 months, NSE:ACCPL has paid 34.16 million in taxes.

Income Tax	34.16M
Effective Tax Rate	26.11%

Stock Price Statistics

The stock price has increased by +67.81% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+67.81%
50-Day Moving Average	91.18
200-Day Moving Average	74.67
Relative Strength Index (RSI)	60.63
Average Volume (20 Days)	52,200

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:ACCPL had revenue of INR 898.18 million and earned 96.68 million in profits. Earnings per share was 9.03.

Revenue	898.18M
Gross Profit	246.65M
Operating Income	139.31M
Pretax Income	130.83M
Net Income	96.68M
EBITDA	151.42M
EBIT	139.31M
Earnings Per Share (EPS)	9.03

Balance Sheet

The company has 40.21 million in cash and 123.21 million in debt, with a net cash position of -83.01 million or -7.47 per share.

Cash & Cash Equivalents	40.21M
Total Debt	123.21M
Net Cash	-83.01M
Net Cash Per Share	-7.47
Equity (Book Value)	547.09M
Book Value Per Share	49.27
Working Capital	397.81M

Cash Flow

In the last 12 months, operating cash flow was -146.21 million and capital expenditures -85.34 million, giving a free cash flow of -231.55 million.

Operating Cash Flow	-146.21M
Capital Expenditures	-85.34M
Depreciation & Amortization	12.11M
Net Borrowing	-17.82M
Free Cash Flow	-231.55M
FCF Per Share	-20.83

Margins

Gross margin is 27.46%, with operating and profit margins of 15.51% and 10.76%.

Gross Margin	27.46%
Operating Margin	15.51%
Pretax Margin	14.57%
Profit Margin	10.76%
EBITDA Margin	16.86%
EBIT Margin	15.51%
FCF Margin	n/a

Dividends & Yields

NSE:ACCPL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.57%
Shareholder Yield	-33.57%
Earnings Yield	7.40%
FCF Yield	-17.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3